TSS
KRSA

Two Sigma Securities’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Two Sigma Securities’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-145
Closed -$17K – 2695
2022
Q3 		$17K Sell
145
-245
-63% -$4.21K ﹤0.01% 2317
2022
Q2 		$30K Buy
+390
New +$5.59K ﹤0.01% 1903

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TFS
TrustCore Financial Services Brentwood, Tennessee $1.14B AUM 13.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Securities's KRSA Position: Q4 2022 in Review

Two Sigma Securities sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q4 2022, closing a stake of 145 shares — an estimated $17K sold.

Two Sigma Securities first reported a position in KRSA in Q2 2022 and held it in 2 quarters. The position peaked at $30K in Q2 2022. 33 funds tracked by Wall St. Rank hold KRSA as of Q4 2022.

  • Two Sigma Securities reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 145 Korsana Biosciences, Inc. Common Stock shares in Q4 2022, an estimated $17K.
  • Two Sigma Securities first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Two Sigma Securities's Korsana Biosciences, Inc. Common Stock position peaked at $30K in Q2 2022.
  • 33 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.